NCT02762162

Brief Summary

ONASSIST is a registry of coronary ill patients who have had a functional test measuring anti-platelet effect and/or a genetic profile of response to anti-platelet drugs.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
128mo left

Started Jan 2007

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress65%
Jan 2007Jan 2037

Study Start

First participant enrolled

January 1, 2007

Completed
9.3 years until next milestone

First Submitted

Initial submission to the registry

May 3, 2016

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 4, 2016

Completed
10.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2027

Expected
10 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2037

Last Updated

January 30, 2019

Status Verified

January 1, 2019

Enrollment Period

20 years

First QC Date

May 3, 2016

Last Update Submit

January 29, 2019

Conditions

Acute Coronary SyndromePercutaneous Coronary InterventionMyocardial Infarction

Keywords

antiplateletstent thrombosis

Outcome Measures

Primary Outcomes (6)

  • Bleeding

    all bleeding according to the BARC (Bleeding Academic Research Consortium) definitions are registered during the follow up

    10 years

  • Myocardial Infarction

    10 years

  • Death

    10 years

  • Stroke

    10 years

  • Urgent Revascularization

    10 years

  • Resuscitated Cardiac Arrest

    10 years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

coronary ill patients who have had a functionnal test mesuring antiplatelet effect and / or a genetic profile of response to antiplatelet drugs.

You may qualify if:

  • coronary disease
  • antiplatelets testing performed as part of usual care and / or gentic profile of antiplatelet response done

You may not qualify if:

  • patient refusing to be part of the registry

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Pitie Salpetriere

Paris, 75013, France

RECRUITING

MeSH Terms

Conditions

Acute Coronary SyndromeMyocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Central Study Contacts

Jean Philippe COLLET, MD, PhD

CONTACT

+33142162962jean-philippe.collet@aphp.fr

Delphine Brugier, PhD

CONTACT

+33142162918delphine.brugier-ext@aphp.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2016

First Posted

May 4, 2016

Study Start

January 1, 2007

Primary Completion (Estimated)

January 1, 2027

Study Completion (Estimated)

January 1, 2037

Last Updated

January 30, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will share

Locations

FR(1)